ABT and MDT Related Headlines
Go Back- Piper Sandler's Key Takeaways From CRT 2026
- Bernstein Highlights Top U.S. Medtech 2026 Picks: 'Sector Poised For a Rebound'
- Bernstein Shares Takeaways From the 5th Annual Diabetes Disruptor Conference
- Needham: 'we believe that the Section 232 investigation creates a new overhang for the already beleaguered medical device sector'
- Piper Sandler on calls with diabetes clinicians
